1. Home
  2. RCUS vs ATS Comparison

RCUS vs ATS Comparison

Compare RCUS & ATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.00

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$30.76

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
ATS
Founded
2015
1978
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
RCUS
ATS
Price
$22.00
$30.76
Analyst Decision
Buy
Hold
Analyst Count
9
1
Target Price
$28.89
$35.00
AVG Volume (30 Days)
1.6M
93.8K
Earning Date
02-24-2026
02-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$240,000,000.00
$1,930,283,080.00
Revenue This Year
N/A
$16.92
Revenue Next Year
N/A
$5.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$20.90
52 Week High
$26.40
$32.73

Technical Indicators

Market Signals
Indicator
RCUS
ATS
Relative Strength Index (RSI) 47.16 69.94
Support Level $20.59 $28.18
Resistance Level $23.40 $31.03
Average True Range (ATR) 1.39 0.77
MACD -0.07 0.18
Stochastic Oscillator 32.38 90.58

Price Performance

Historical Comparison
RCUS
ATS

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

Share on Social Networks: